For investors looking to join solid fundamental growth with well-timed technical entry points, a multi-layered screening method can be very useful. One approach is to look for stocks that show forceful earnings momentum, good technical condition, and a positive chart formation ready for a possible breakout. This method tries to find companies that are not just increasing at a fast rate but also trading in a way that points to institutional buying and a favorable entry point. TRANSMEDICS GROUP INC (NASDAQ:TMDX) recently appeared from a scan looking for securities with a High Growth Momentum (HGM) Rating above 4, a Technical Rating above 7, and a Setup Rating above 7, making a strong argument for more review.
The center of this method is found in the combination of three proprietary ChartMill ratings. The High Growth Momentum Rating judges short-term earnings strength, searching for speed, positive surprises, and rising analyst changes. The Technical Rating measures the stock's trend force and relative performance. Finally, the Setup Rating measures the quality of a consolidation formation, looking for narrow trading ranges that frequently come before a new upward move. A stock with high marks in all three areas indicates it has the fundamental driver, market approval, and chart shape that growth and momentum investors look for.
Fundamental Growth Momentum
TransMedics displays the type of forceful earnings increase that builds the foundation of the momentum method. The company's latest quarterly report shows notable speed, a main part of the HGM Rating.
- Earnings Per Share (EPS) Growth: The year-over-year EPS increase has been very high, with the latest quarter reaching 178.9%. More notable is the sequential speed from the earlier quarters, which showed growth of 450% and 162.9%.
- Consistent Earnings Surprises: The company has exceeded EPS estimates in each of the past four quarters, with an average surprise above 96%. This steady outperformance shows management results are beating market forecasts, a good sign for future changes.
- Increasing Profitability: Beyond sales growth, which stays solid above 32% last quarter, TransMedics is showing important operating leverage. The profit margin in the last reported quarter jumped to 65.6%, up greatly from 16.9% and 22.2% in the two previous quarters. This margin growth is a key sign of a business scaling effectively.
While analyst forecasts point to a slowing in the very high EPS growth rate in the coming next quarter, the set pattern of high growth, positive surprises, and rising profitability supports the stock's good HGM Rating of 6. This score shows a company in a forceful fundamental upward trend, a main filter for momentum-based methods.
Technical Strength and Setup Quality
A good growth story must be supported by price action, and TransMedics' chart shows clear technical condition. According to the detailed ChartMill Technical Analysis Report, TMDX receives a high Technical Rating of 9 out of 10.
- Trend Position: Both the long-term and short-term trends are graded as positive, a preferred situation for momentum investing. The stock is trading above its important moving averages (20, 50, 100, and 200-day), which are all moving up, confirming a continued uptrend.
- Relative Strength: TMDX is doing better than 95% of similar companies in the Health Care Equipment & Supplies industry and 92% of all stocks in the market over the past year. This leadership is a trait of stocks preferred by institutional investors.
- Consolidation and Setup: Maybe most relevant for entry timing is the Setup Rating of 7. The report states "reduced volatility while prices have been consolidating in the latest period." After a notable rise, the stock has been trading in a range between about $127 and $151 over the past month, letting it absorb gains and form a new base of support. The review finds a clear resistance area just above the current price near $146.32 and a support area below near $136.76, giving specific levels for possible breakout entries and protective stop-loss orders.
This pairing, a high technical rating confirming the uptrend and a good setup rating pointing out a consolidation, indicates the stock is not overbought. Instead, it is pausing within its longer-term rise, possibly giving a planned entry point on a clear move above the noted resistance.
Conclusion
TransMedics Group presents a situation where fundamental momentum and technical shape match. The company's outstanding recent earnings growth, margin growth, and record of exceeding estimates meet the central requirements for high-growth momentum investing. At the same time, its chart shows a good upward trend with a recent time of consolidation, offering a measurable setup for traders. This link between a forceful business path and positive price action is exactly what the combined screening process is made to find.
For investors wanting to review other stocks that meet this particular mix of growth, trend, and setup requirements, the scan that found TMDX can be found here: High Growth Momentum Breakout Setups Screen.
Disclaimer: This article is for information only and does not make up financial advice, a support, or a suggestion to buy, sell, or hold any security. Investing has risk, including the possible loss of principal. Always do your own complete research and think about your personal financial situation and risk tolerance before making any investment choices.
